Loading…
Lobbying Income
$1.6M
Filings
16
Unique Clients
1
Active Period
2006–2010
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Improving Mathematics and Science Teacher Quality Act
2010 · third_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Implementation of Health Care Reform Law, Patient Protection and Affordable Care Act of 2010, H.R. 3950
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3950
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
2010 · second_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Issues invloving implementation of Patient Protection and Affordabile Care Act (H.R. 3950) Health Care and Education Affordability Reconcilliation Act (H.R 4872)
Client expense: — · Firm income: $90,000
Matched citations: H.R 4872
Improving Mathematics and Science Teacher Quality Act
2010 · second_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Issues invloving implementation of Patient Protection and Affordabile Care Act (H.R. 3950) Health Care and Education Affordability Reconcilliation Act (H.R 4872)
Client expense: — · Firm income: $90,000
Matched citations: H.R. 3950
Preserve Access to Affordable Generics Act
2010 · second_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Patent Reform Bills (S. 515) Preserve Access to Affordable Generics Act S. 369
Client expense: — · Firm income: $90,000
Matched citations: S. 369
Patent Reform Act of 2009
2010 · second_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Patent Reform Bills (S. 515) Preserve Access to Affordable Generics Act S. 369
Client expense: — · Firm income: $90,000
Matched citations: S. 515
American Middle Class Tax (AMT) Relief Act of 2007
2010 · first_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R.2872)
Client expense: — · Firm income: $90,000
Matched citations: H.R. 3590
Medicare Quality Cancer Care Demonstration Project Act of 2009
2010 · first_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Patient Protection and Affordable Care Act (H.R. 3590) Health Care and Education Affordability Reconciliation Act (H.R.2872)
Client expense: — · Firm income: $90,000
Matched citations: H.R.2872
American Middle Class Tax (AMT) Relief Act of 2007
2009 · fourth_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
H.R. 3590 The Patient Protection and Affordable Care Act H.R. 3962 The Affordable Health Care for America Act
Client expense: — · Firm income: $90,000
Matched citations: H.R. 3590
Superfund Polluter Pays Act
2009 · fourth_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
H.R. 3590 The Patient Protection and Affordable Care Act H.R. 3962 The Affordable Health Care for America Act
Client expense: — · Firm income: $90,000
Matched citations: H.R. 3962
Pathway for Biosimilars Act
2009 · third_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
HR 3200 America's Affordable Health Care Choices Act of 2009 Senate Comprehensive Health Reform legislation "America's Healthy Future Act of 2009"/ S 1679 Affordable Health Choices Act HR 1548 Pathway for Biosimilars Act S 1213 Patient Centered Outcomes Research Act/ HR 2502 Comparative Effectiveness Research Act of 2009
Client expense: — · Firm income: $90,000
Matched citations: HR 1548
Comparative Effectiveness Research Act of 2009
2009 · third_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
HR 3200 America's Affordable Health Care Choices Act of 2009 Senate Comprehensive Health Reform legislation "America's Healthy Future Act of 2009"/ S 1679 Affordable Health Choices Act HR 1548 Pathway for Biosimilars Act S 1213 Patient Centered Outcomes Research Act/ HR 2502 Comparative Effectiveness Research Act of 2009
Client expense: — · Firm income: $90,000
Matched citations: HR 2502
America's Affordable Health Choices Act of 2009
2009 · third_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
HR 3200 America's Affordable Health Care Choices Act of 2009 Senate Comprehensive Health Reform legislation "America's Healthy Future Act of 2009"/ S 1679 Affordable Health Choices Act HR 1548 Pathway for Biosimilars Act S 1213 Patient Centered Outcomes Research Act/ HR 2502 Comparative Effectiveness Research Act of 2009
Client expense: — · Firm income: $90,000
Matched citations: HR 3200
Patient-Centered Outcomes Research Act of 2009
2009 · third_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
HR 3200 America's Affordable Health Care Choices Act of 2009 Senate Comprehensive Health Reform legislation "America's Healthy Future Act of 2009"/ S 1679 Affordable Health Choices Act HR 1548 Pathway for Biosimilars Act S 1213 Patient Centered Outcomes Research Act/ HR 2502 Comparative Effectiveness Research Act of 2009
Client expense: — · Firm income: $90,000
Matched citations: S 1213
Affordable Health Choices Act
2009 · third_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
HR 3200 America's Affordable Health Care Choices Act of 2009 Senate Comprehensive Health Reform legislation "America's Healthy Future Act of 2009"/ S 1679 Affordable Health Choices Act HR 1548 Pathway for Biosimilars Act S 1213 Patient Centered Outcomes Research Act/ HR 2502 Comparative Effectiveness Research Act of 2009
Client expense: — · Firm income: $90,000
Matched citations: S 1679
Pathway for Biosimilars Act
2009 · second_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Affordable Health Choices Act (Senate Legislation) HR 3200 America's Affordable Health Care Choices Act of 2009 HR 1548 Pathway for Biosimilars Act S. 1213 Patient Centered Outcomes Research Act/ HR 2502 Comparative Effectiveness Research Act of 2009
Client expense: — · Firm income: $90,000
Matched citations: HR 1548
Comparative Effectiveness Research Act of 2009
2009 · second_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Affordable Health Choices Act (Senate Legislation) HR 3200 America's Affordable Health Care Choices Act of 2009 HR 1548 Pathway for Biosimilars Act S. 1213 Patient Centered Outcomes Research Act/ HR 2502 Comparative Effectiveness Research Act of 2009
Client expense: — · Firm income: $90,000
Matched citations: HR 2502
America's Affordable Health Choices Act of 2009
2009 · second_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Affordable Health Choices Act (Senate Legislation) HR 3200 America's Affordable Health Care Choices Act of 2009 HR 1548 Pathway for Biosimilars Act S. 1213 Patient Centered Outcomes Research Act/ HR 2502 Comparative Effectiveness Research Act of 2009
Client expense: — · Firm income: $90,000
Matched citations: HR 3200
Patient-Centered Outcomes Research Act of 2009
2009 · second_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Affordable Health Choices Act (Senate Legislation) HR 3200 America's Affordable Health Care Choices Act of 2009 HR 1548 Pathway for Biosimilars Act S. 1213 Patient Centered Outcomes Research Act/ HR 2502 Comparative Effectiveness Research Act of 2009
Client expense: — · Firm income: $90,000
Matched citations: S. 1213
American Recovery and Reinvestment Act of 2009
2009 · first_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
HR 1 American Recovery and Reinvestment Act of 2009 S. 336 American Recovery and Reinvestment Act of 2009 S.350 American Recovery and Reinvestment Act of 2009
Client expense: — · Firm income: $90,000
Matched citations: S. 336
American Recovery and Reinvestment Act of 2009
2009 · first_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
HR 1 American Recovery and Reinvestment Act of 2009 S. 336 American Recovery and Reinvestment Act of 2009 S.350 American Recovery and Reinvestment Act of 2009
Client expense: — · Firm income: $90,000
Matched citations: S.350
Patent Reform Act of 2009
2009 · first_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
S 515 Patent Reform Act of 2009
Client expense: — · Firm income: $90,000
Matched citations: S 515
Patent Reform Act of 2007
2008 · fourth_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Patent Reform - S. 1145, HR 1908
Client expense: — · Firm income: $90,000
Matched citations: HR 1908
Medicare Improvements for Patients and Providers Act of 2008
2008 · fourth_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Medicare Improvement for Patients and Providers Act - HR 6331
Client expense: — · Firm income: $90,000
Matched citations: HR 6331
Patent Reform Act of 2007
2008 · fourth_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Patent Reform - S. 1145, HR 1908
Client expense: — · Firm income: $90,000
Matched citations: S. 1145
False Claims Act Correction Act of 2008
2008 · fourth_quarter · Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Sunshine Act S. 20299; False Claims Act S. 2041
Client expense: — · Firm income: $90,000
Matched citations: S. 2041
Source: Senate LDA